ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,133.62
1.37%
Dow Jones
38,723.22
1.30%
US Dollar vs MXN
16.96741
-0.03%
Brent Oil
82.93
-0.84%
Bitcoin
61,787.73
4.51%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Protalix BioTherapeutics Inc (PLX)

  7. Protalix BioTherapeutics Inc (PLX) Noticias

PLX

Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:PLX
FechaHoraFuenteTítuloSímboloCompañía
02/01/202405:36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
26/12/202305:56Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
30/11/202303:00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
06/11/202306:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
31/10/202315:40AllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
20/10/202305:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
15/09/202315:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
06/09/202305:50PR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
11/08/202315:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:PLXProtalix BioTherapeutics Inc
07/07/202315:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PLXProtalix BioTherapeutics Inc
29/06/202306:25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202315:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202315:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
18/05/202316:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202307:27Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:PLXProtalix BioTherapeutics Inc
01/05/202305:48Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202306:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202305:47Edgar (US Regulatory)Annual Report (10-k)AMEX:PLXProtalix BioTherapeutics Inc
03/01/202305:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:PLXProtalix BioTherapeutics Inc
14/11/202206:08Edgar (US Regulatory)Quarterly Report (10-q)AMEX:PLXProtalix BioTherapeutics Inc
09/09/202216:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PLXProtalix BioTherapeutics Inc
14/07/202215:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:PLXProtalix BioTherapeutics Inc
05/07/202215:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:PLXProtalix BioTherapeutics Inc
09/06/202213:53Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202205:26Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:PLXProtalix BioTherapeutics Inc
20/04/202215:50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:PLXProtalix BioTherapeutics Inc
23/10/202016:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:PLXProtalix BioTherapeutics Inc
14/08/202016:03Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:PLXProtalix BioTherapeutics Inc
01/06/202016:22Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:PLXProtalix BioTherapeutics Inc
29/04/202016:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:PLXProtalix BioTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:PLX

Su Consulta Reciente

AMEX
XLF
Financial Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
VZ
Verizon Communications
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
FX
EURMXN
Euro vs MXN
SPI
SP500
S&P 500
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
NYSE
NKE
Nike
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
FX
EURUSD
Euro vs US Dollar
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados